Speakers
Adam Gilbert
Executive Director, External Innovation Accelerator
Pfizer
Akihiro Furukawa
Director, Research & Technology Search & Evaluation
Daiichi Sankyo
Alexandra Joseph
Chief Scientific Officer
Photys Therapeutics
Andrew Combs
Chief Chemistry Officer
Prelude Therapeutics
Ann Rowley
Director Targeted Protein Degradation
Merck
Anna Rivkin
Chief Business Officer
Foghorn Therapeutics
Arnout Schepers
Chief Executive Officer
TenAces Biosciences
Brad Heckmann
Chief Scientific Officer
ASHA Therapeutics
Bret Williams
Senior Vice President of Research
Magnet Biomedicine
Carla Bauer
Director, Oncology Search and Evaluation, Business Development
Merck
Christopher Guenard
Vice President Corporate Development
Photys Therapeutics
Danette Daniels
Vice President, Protein Degrader Platform
Foghorn Therapeutics
Elena Diez
Senior Director External Innovation
Janssen
Giovanni Spagnolli
Co-founder & Chief Technology Officer
Sibylla Biotech
Gwenn Hansen
Chief Scientific Officer
Nurix Therapeutics
Miki Hayano
Business Development
Monte Rosa Therapeutics
Randolph Lopez
Chief Technology Officer & Co-Founder
A-Alpha Bio
Reza Mazhari
Chief Business Officer
TRIANA Biomedicines
Seth Goldblum
Senior Vice President - Corporate Development
Cullgen
Shu-Jen Chen
Chief Scientific Officer
AnHorn Medicines
Xiaodong Zhang
Business Development Search & Evaluation, Oncology & Haematology
Novartis
Yue Xiong
Chief Scientific Officer
Cullgen